BIOMAT Database Logo BIOMAT Database Logo

A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection. 1993

B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

A pilot study was initiated to explore a sequential combination antiretroviral regimen in 21 patients with AIDS or advanced human immunodeficiency virus (HIV) infection, who had received little or no prior anti-HIV therapy. The mean entry CD4 cell count was 184/mm3. Patients received 3-week cycles consisting of zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine for 1 week each. Overall, the regimen was well tolerated for up to 3 years. The principal toxicities were anemia, nausea, and vomiting; 1 patient developed retinal lesions. The mean CD4 cell count reached a peak of 64 cells/mm3 above baseline at week 8 (P = .005 compared to baseline) and remained above baseline for > 40 weeks. Patients also gained weight and had decreases in serum HIV p24 antigen. Eight patients developed opportunistic infections or tumors. Only 4 patients died during 3 years of follow-up. This regimen appears to be generally tolerable and to have anti-HIV activity. Additional studies will be needed, however, to learn how to best combine the available agents in patients with HIV infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
January 1992, Annals of internal medicine,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
November 1993, German journal of ophthalmology,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Study of human immunodeficiency virus resistance to 2'-3'-dideoxyinosine and zidovudine in sequential isolates from pediatric patients on long-term therapy.
April 1993, The Journal of infectious diseases,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.
November 1991, Antimicrobial agents and chemotherapy,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
October 1990, The New England journal of medicine,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection.
January 1994, The Journal of infectious diseases,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
[Dideoxycytidine and dideoxyinosine: new therapy for acquired immunodeficiency syndrome?].
July 1991, Harefuah,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.
September 1996, Journal of virology,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
November 1990, The Journal of pediatrics,
B Y Nguyen, and L E Shay, and K M Wyvill, and J M Pluda, and O Brawley, and R B Cohen, and S M Whitcup, and D J Venzon, and S Broder, and R Yarchoan
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
January 1988, Lancet (London, England),
Copied contents to your clipboard!